News About: Pharm. Industry
Mr. Rob Smith named CEO of Lilly Korea.Mr. Rob Smith was nominated as the chief executive officer of E. Lilly Korea effective from Sept. 1 this year. He graduated from Bradford University in UK in 1979 majoring appli...
|
Domestic pharmaceutical industry likely to find momentum in third quarter
Korean pharmaceutical industry is expected to gain momentum in the third quarter of this year due to favorable internal factors, said a local analyst in a pharmaceutical report.
The report said that investors will...
Drug industry to put more weight on pharmacy business.
To improve the management and business profits, the drug industry tried to expand their business volume more in the retail pharmacy market.
Despite the current general economy slow the pharmaceutical business has a...
Pediatric Singulair use recommended
MSD Korea said that it has launched Singulair (montelukast sodium) 4 mg granule for the prevention and treatment of asthma and allergic rhinitis in children.
Singulair granule, a tasteless powder form, is a once-a-...
Yuyu wins EU patent for anti-dementia agent
Yuyu Pharm said it has won a patent from European Union for its novel pharmaceutical composition containing selegiline and gingko biloba extract for the treatment of dementia, following the acquisition of the Korea pa...
Hanmi seeking global sales plan for Amodipine.
An explanatory meeting for amlodipine generic drugs was arranged by Hanmi following Chonkundang for 20 members of "Thursday Club", a wholesaler's club, in presence of other 3 city and provincial wholesale association ...
Green Cross and Green Cross BC to merge.
Green Cross announced on Aug. 26 that its subsidiary Green Cross BC, a consulting company, and Green Cross Medical Engineering would be merged after completing their business registration.
Green Cross currently ...
First-version generics predicted to exceed 30-70% of domestic pharmaceutical market
Pharmaceutical business sources said that Korean first-version generic drugs, such as amlodipine and glimepiride, may make up more than 30 to 70 percent in less than 10 years, thanks to local doctors' changed percepti...
Generic drugs beneficial to local clinic markets.
By taking occasion for the glimepiride and amlodipine generic drugs to launch in Sept. many pharmaceutical firms would try to concentrate their marketing activities into the private clinic markets, which may give a lo...
Pharmaceutical firms face damage suit over cold remedies
Recently, six Korean people filed a 500 million won damage suit against the government and some cold drug makers, claiming they had suffered side effects from medicines containing phenylpropanolamine (PPA), which alle...
